Abstract: An electrical terminal for connecting a magnetic wire to a connector includes a flat wire contact portion for electrically connecting and hosting the magnetic wire, and a connector tab for the insertion into the connector, for example a RAST 2.5 connector. The connector tab is bended so as to include at least two parallel surfaces opposite to one another, separated by an empty space.

Abstract: A plug connector includes a plug housing extending between a front and a rear. The front configured to be mated with a header housing. The plug housing includes contact channels extending longitudinally between the front and the rear. The plug connector includes contacts received in the contact channels. The contacts include sockets at mating ends of the contacts configured to receive pin contacts of the header housing. The contacts are arranged in an array has multiple rows and multiple columns. The plug connector includes a contact organizer coupled to the front of the plug housing. The contact organizer has bores therethrough aligned with the corresponding contact channels. The contact organizer has guide features configured to center the pin contacts in the bores to align the pin contacts with the sockets.

Abstract: A connector terminal includes a clamping part and a contacting part. A side of a first end of the clamping part has a first barb structure and a pair of sides of a second end of the clamping part each have a second barb structure. The first end is opposite to the second end. The contacting part extends along a first direction from the second end of the clamping part and electrically contacts a terminal paired with the connector terminal.

Abstract: An insulation displacement contact (IDC) cluster includes a plurality of IDC cluster modular units each having a plurality of receptacles adjacent to one another in a row. Each of the receptacles receives an IDC terminal. A first IDC cluster modular unit of the IDC cluster modular units is coupled to a second IDC cluster modular unit of the IDC cluster modular units to form a modular structure by stacking and fastening together, arranging the receptacles of the IDC cluster modular units in parallel rows.

Abstract: A conductive terminal includes a first pair of clamping arms forming a first clamping portion for connecting with a wire, and a second pair of clamping arms connected to the first pair of clamping arms by a connecting part. The first clamping portion has a first clamping sub-portion and a second clamping sub-portion distributed along a length direction. The second pair of clamping arms forms a second clamping portion. The second clamping portion has a third clamping sub-portion and a fourth clamping sub-portion distributed along the length direction. The first clamping sub-portion corresponds to the third clamping sub-portion in the length direction. A width of the first clamping sub-portion is greater than a width of the third clamping sub-portion. The second clamping sub-portion corresponds to the fourth clamping sub-portion in the length direction. A width of the second clamping sub-portion is less than a width of the fourth clamping sub-portion.

Abstract: An insulation displacement contact (IDC) cluster includes a plurality of IDC cluster modular units each having a plurality of receptacles adjacent to one another in a row. Each of the receptacles receives an IDC terminal. A first IDC cluster modular unit of the IDC cluster modular units is coupled to a second IDC cluster modular unit of the IDC cluster modular units to form a modular structure by stacking and fastening together, arranging the receptacles of the IDC cluster modular units in parallel rows.

Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general Formula I: and to pharmaceutical compositions having antitumor action.

Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general and to pharmaceutical compositions having antitumor action.

Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general Formula I: 1

Abstract: The side effect of decrease in body weight caused by the alkylphosphocholines such as miltefosine can be antagonized by certain acetylcholine receptor antagonists such as domperidone and pimozide. The combination of alkylphosphocholine plus the antagonist does not have any effect on the anti-tumor action of the alkylphosphocholine. The combination also caused no new side effects in the animals.

Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general Formula I and to pharmaceutical compositions having antitumor action.

Abstract: The invention relates to novel indole and heteroindole derivatives of the formula I 1

Abstract: The object of the invention is then to widen the field of use of N-substituted indole-3-glyoxylamides and thus to enrich the available pharmaceutical wealth. The possibility of a lower, longer-lasting and better-tolerable medication for the class of substances having antitumor action described in German Patent Application 19814 838.0 should thus be opened up. In particular, the disadvantageous development of resistance, as is known of many antitumor agents, should be circumvented.

Abstract: The side effect of decrease in body weight caused by the alkylphosphocholines such as miltefosine can be antagonized by certain acetylcholine receptor antagonists such as domperidone and pimozide. The combination of alkylphosphocholine plus the antagonist does not have any effect on the anti-tumor action of the alkylphosphocholine. The combination also caused no new side effects in the animals.

Abstract: The present invention relates to new solid pharmaceutical compositions containing hexadecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis, a process for the manufacture of said pharmaceutical composition, a dosage scheme for oral administration of said pharmaceutical composition in the treatment of leishmaniasis, and finally a combination comprising said solid pharmaceutical composition, antiemeticum, and/or an antidiarrhoeal.

Abstract: The side effect of decrease in body weight caused by the alkylphosphocholines such as miltefosine can be antagonized by certain acetylcholine receptor antagonists such as domperidone and pimozide. The combination of alkylphosphocholine plus the antagonist does not have any effect on the anti-tumor action of the alkylphosphocholine. The combination also caused no new side effects in the animals.

Abstract: The invention relates to novel indole and heteroindole derivatives of the formula I 1

Abstract: This invention relates to novel xanthone compounds, their preparation and use as medicament. More particularly this invention is directed to the isolation of the novel xanthone natural product sootepenseone from Dasymaschalon sootepense Craib, Annonaceae, its identification and derivatization, and the use of sootepenseone and its derivatives as anticancer agents.

Abstract: An adaptor for connecting a chip card to a PCMCIA-standard computer slot has a housing with a top cover, a separate bottom cover, and at least one intermediate insulative element or frame connecting the top cover to the bottom cover at a spacing to one another. The top cover and bottom cover have substantially congruent outer contours. The housing has a receiving channel. A printed circuit board is mounted in the housing and extends parallel to the receiving channel. The circuit board has contact elements for electrically contacting a chip card received in the receiving channel. The housing has a front face and a back face wherein the front face has an insertion slot communicating with the receiving channel. The back face has a contact plug electrically connected to the printed circuit board and adapted to electrically contact the PCMCIA-standard computer slot. Cams at the channel entrance are used for card retention.

Abstract: The side effect of decrease in body weight caused by the alkylphosphocholines such as miltefosine can be antagonized by certain acetylcholine receptor antagonists such as domperidone and pimozide. The combination of alkylphosphocholine plus the antagonist does not have any effect on the anti-tumor action of the alkylphosphocholine. The combination also caused no new side effects in the animals.